Prestige Consumer Healthcare (PBH) Enterprise Value (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Enterprise Value of -$62.4 million in Q4 2025, up 47.63% quarter-over-quarter from -$119.1 million in Q3 2025, and down 22.6% on a YoY basis from -$80.6 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Enterprise Value (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Enterprise Value history runs 16 years deep, the most recent figure standing at -$62.4 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 22.6% year-over-year to -$62.4 million; the TTM figure through Dec 2025 stood at -$62.4 million (down 22.6% YoY), while the FY2025 annual figure was -$97.9 million, down 110.64% from the prior year.
- Enterprise Value was -$62.4 million for Q4 2025 at Prestige Consumer Healthcare, up from -$119.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$21.0 million in Q4 2021 to a low of -$163.6 million in Q2 2021.
- Historically, Enterprise Value has averaged -$64.5 million across 5 years, with a median of -$53.1 million in 2023.
- Biggest YoY gain for Enterprise Value was 78.08% in 2022; the steepest drop was 310.88% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$21.0 million in 2021, then plunged by 310.88% to -$86.4 million in 2022, then climbed by 26.34% to -$63.6 million in 2023, then rose by 20.03% to -$50.9 million in 2024, then fell by 22.6% to -$62.4 million in 2025.
- The last three Enterprise Value figures came in at -$62.4 million (Q4 2025), -$119.1 million (Q3 2025), and -$139.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -498.58 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | -62.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -62.37 Mn |
| Sep 30, 2025 | -119.11 Mn |
| Jun 30, 2025 | -139.50 Mn |
| Mar 31, 2025 | -97.88 Mn |
| Dec 31, 2024 | -50.87 Mn |
| Sep 30, 2024 | -51.54 Mn |
| Jun 30, 2024 | -34.26 Mn |
| Mar 31, 2024 | -46.47 Mn |
| Dec 31, 2023 | -63.62 Mn |
| Sep 30, 2023 | -60.07 Mn |
| Jun 30, 2023 | -54.58 Mn |
| Mar 31, 2023 | -58.49 Mn |
| Dec 31, 2022 | -86.36 Mn |
| Sep 30, 2022 | -42.44 Mn |
| Jun 30, 2022 | -35.87 Mn |
| Mar 31, 2022 | -27.19 Mn |
| Dec 31, 2021 | -21.02 Mn |
| Sep 30, 2021 | -42.82 Mn |
| Jun 30, 2021 | -163.62 Mn |
| Mar 31, 2021 | -32.30 Mn |